Shilpa Medicare Gains 5% on Launch of Generic Drug
Shares of Shilpa Medicare gained as much as 5.23 per cent after the company launched generic drug to treat advanced kidney cancer. Shilpa Medicare was...
Download Unicorn Signals App
Powered By EquityPandit
